John C. Jacobs - 23 Jan 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: President and CEO, Director
Signature: /s/Mark J. Casey, Attorney-in-Fact
Issuer symbol: NVAX
Transactions as of: 23 Jan 2025
Net transactions value: -$371,237
Form type: 4
Filing time: 27 Jan 2025, 18:19:02 UTC
Previous filing: 26 Mar 2024
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVAX	Common Stock	Options Exercise	$0	+83,196	+175%	$0.000000	130,722	23 Jan 2025	Direct
transaction	NVAX	Common Stock	Tax liability	$371,237	-38,873	-30%	$9.55	91,849	23 Jan 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Restricted Stock Units	Options Exercise	$0	-83,196	-50%	$0.000000	83,197	23 Jan 2025	Common Stock	83,196	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.